Work

IMpower133: Phase I/III trial of first-line atezolizumab with carboplatin and etoposide in ES-SCLC

Year: 2017

Type: article

Source: Annals of Oncology

DOI: 10.1093/annonc/mdx088.008

Authors: M. Reck, A.S. Mansfield, S.V. Liu, T.S.K. Mok, X. Tang, S. Lam, F. Kabbinavar, A. Lopez-Chavez, A. Sandler, L. Horn

Institutions: German Center for Lung Research, Mayo Clinic, Georgetown University, Georgetown Lombardi Comprehensive Cancer Center, Chinese University of Hong Kong, F. Hoffmann-La Roche AG, Genentech, Vanderbilt University, Vanderbilt-Ingram Cancer Center

Language: English

Topic: Lung Cancer Research Studies

Subfield: Oncology

Field: Medicine

Domain: Health Sciences

SDG: Good health and well-being

Open Access status: bronze

OpenAlex ID: W2612142788

FWCI:

Cites:

Cited by:

Related to: 10